Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
| Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Opioid prescribing trends and changes during COVID-19 | opioids-covid-research | 19572 | TPP | 1/1 | Andrea Schaffer | 2 years, 11 months ago 07 August 2023 13:11:26 UTC | View, Job request 19572 |
| Succeeded | Opioid prescribing trends and changes during COVID-19 | opioids-covid-research | 19567 | TPP | 1/1 | Andrea Schaffer | 2 years, 11 months ago 07 August 2023 12:45:42 UTC | View, Job request 19567 |
| Succeeded | Opioid prescribing trends and changes during COVID-19 | opioids-covid-research | 19566 | TPP | 1/1 | Andrea Schaffer | 2 years, 11 months ago 07 August 2023 12:09:49 UTC | View, Job request 19566 |
| Succeeded | Impact of COVID-19 on diabetes care in England | covid-diabetes-care | 19560 | TPP | 5/5 | Alex Walker | 2 years, 11 months ago 07 August 2023 08:55:21 UTC | View, Job request 19560 |
| Succeeded | Impact of COVID-19 on diabetes care in England | covid-diabetes-care | 19552 | TPP | 1/1 | Alex Walker | 2 years, 11 months ago 06 August 2023 23:50:22 UTC | View, Job request 19552 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 19538 | TPP | 0/1 | Bang Zheng | 2 years, 11 months ago 05 August 2023 12:42:12 UTC | View, Job request 19538 |
| Succeeded | Validation of ISARIC / SUS / PHOSP data for COVID-related hospital admissions | isaric-translation | 19532 | TPP | 1/1 | Millie Green | 2 years, 11 months ago 05 August 2023 01:37:44 UTC | View, Job request 19532 |
| Succeeded | Validation of ISARIC / SUS / PHOSP data for COVID-related hospital admissions | isaric-translation | 19531 | TPP | 1/1 | Millie Green | 2 years, 11 months ago 04 August 2023 15:17:23 UTC | View, Job request 19531 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | pax-usernonuser | 19530 | TPP | 17/17 | Linda Nab | 2 years, 11 months ago 04 August 2023 15:17:21 UTC | View, Job request 19530 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | pax-usernonuser | 19529 | TPP | 0/1 | Linda Nab | 2 years, 11 months ago 04 August 2023 12:55:53 UTC | View, Job request 19529 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 19523 | TPP | 1/1 | Bang Zheng | 2 years, 11 months ago 03 August 2023 22:12:54 UTC | View, Job request 19523 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | pax-usernonuser | 19522 | TPP | 1/1 | Linda Nab | 2 years, 11 months ago 03 August 2023 19:58:16 UTC | View, Job request 19522 |
| Failed | Opioid prescribing trends and changes during COVID-19 | opioids-covid-research | 19517 | TPP | 1/21 | Andrea Schaffer | 2 years, 11 months ago 03 August 2023 15:44:50 UTC | View, Job request 19517 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | pax-usernonuser | 19513 | TPP | 1/1 | Linda Nab | 2 years, 11 months ago 03 August 2023 15:07:42 UTC | View, Job request 19513 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | pax-usernonuser | 19503 | TPP | 4/5 | Linda Nab | 2 years, 11 months ago 03 August 2023 11:10:54 UTC | View, Job request 19503 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | pax-usernonuser | 19493 | TPP | 1/1 | Linda Nab | 2 years, 11 months ago 03 August 2023 08:00:50 UTC | View, Job request 19493 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | pax-usernonuser | 19492 | TPP | 1/1 | Linda Nab | 2 years, 11 months ago 03 August 2023 07:34:44 UTC | View, Job request 19492 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | pax-usernonuser | 19491 | TPP | 0/1 | Linda Nab | 2 years, 11 months ago 03 August 2023 06:58:52 UTC | View, Job request 19491 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 19490 | TPP | 5/5 | Bang Zheng | 2 years, 11 months ago 03 August 2023 02:21:48 UTC | View, Job request 19490 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 19489 | TPP | 1/2 | Bang Zheng | 2 years, 11 months ago 05 August 2023 06:11:16 UTC | View, Job request 19489 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 19488 | TPP | 1/1 | Bang Zheng | 2 years, 11 months ago 03 August 2023 01:24:36 UTC | View, Job request 19488 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 19487 | TPP | 1/1 | Bang Zheng | 2 years, 11 months ago 03 August 2023 00:44:20 UTC | View, Job request 19487 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | pax-usernonuser | 19471 | TPP | 3/3 | Linda Nab | 2 years, 11 months ago 02 August 2023 15:08:18 UTC | View, Job request 19471 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | pax-usernonuser | 19445 | TPP | 0/1 | Linda Nab | 2 years, 11 months ago 02 August 2023 07:15:50 UTC | View, Job request 19445 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | pax-usernonuser | 19444 | TPP | 1/1 | Linda Nab | 2 years, 11 months ago 02 August 2023 07:03:22 UTC | View, Job request 19444 |